The role of the SHOX gene in the pathophysiology of Turner syndrome

Endocrinologia y Nutricion

Volumn 58, Issue 8, 2011, Pages 433-442

  Oliveira, Conceicao S ^a   Alves, Cresio ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Haploinsufficiency; Hearing loss; Short stature; SHOX gene; Turner syndrome

Indexed keywords

FIBROBLAST GROWTH FACTOR 3; GROWTH HORMONE;

APOPTOSIS; BONE GROWTH; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC SCREENING; GENETIC TRANSCRIPTION; HAPLOINSUFFICIENCY; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; MEDLINE; MUSCULOSKELETAL SYSTEM MALFORMATION; OVARY INSUFFICIENCY; REVIEW; SHORT STATURE; SHORT STATURE HOMEOBOX CONTAINING GENE; TURNER SYNDROME;

EID: 80053582761     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2011.06.005     Document Type: Short Survey

References (55)

1. Bondy C.A. Turner syndrome-2008. Horm Res 2009, 71:52-56.
2. Davenport M.L. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 2010, 95:1487-1495.
3. Ogata T., Muroya K., Matsuo N., Shinohara O., Yorifuji T., Nishi Y., et al. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 2001, 86:5498-5508.
4. Hjerrild B.E., Mortensen C.H., Gravholt C.H. Turner syndrome and clinical treatment. Br Med Bull 2008, 86:77-93.
5. Donaldson M.D.C., Gault E.J., Tan K.W., Dunger D.B. Optimizing management in Turner syndrome: from infancy to adult transfer. Arch Dis Chil 2006, 96:513-520.
6. Ellison J.W., Wardak Z., Young M.F., Gehron R., Laig-Webster M., Chiong W. PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet 1997, 6:1341-1347.
7. Zinn A.R., Roeltgen D., Stefanatos G., Ramos P., Elder F.F., Kushner H., et al. A Turner syndrome neurocognitive phenotype maps to Xp22.3. Behav Brain Funct 2007, 3:1-14.
8. Hintz R. SHOX mutations. Rev Endocr Metab Disord 2002, 3:363-367.
9. Martins R.R.S., Ramos H.I.B., Llerena J.C., Almeida J.C.C. Investigação clínica e genética em meninas com baixa estatura idiopática. Arq Bras Endocrinol Metab 2003, 47:684-694.
10. Jorge A.A.L., Nishi M.Y., Funari M.F.A., Souza S.C., Arnhold I.J.P., Mendonça B.B. Baixa estatura por haploinsuficiência do gene SHOX: do diagnóstico ao tratamento. Arq Bras Endrocrinol Metab 2008, 52:765-773.
11. Day G., Szvetko A., Griffiths L., McPhee I.B., Tuffley J., LaBrom R., et al. SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in Turner syndrome. J Orthop Res 2009, 27:807-813.
12. Goldman B., Polani P.E., Daker M.G., Angeli R.R. Clinical and cytogenetic aspects of X-chromosome deletions. Clin Genet 1982, 21:36-52.
13. Ogata T., Goodfellow P., Petit C., Aya M., Matsuo N. Short stature in a girl with terminal Xp deletion distal to DXYS15: localization of a growth gene(s) in the pseudoautosomal region. J Med Genet 1992, 29:455-459.
14. Funari M.F., Jorge A.A., Souza S.C., Billerbeck A.E., Arnhold I.J., Mendonça B.B., Nishi M.Y. Usefulness of MLPA in the detection of SHOX deletions. Eur J Med Genet 2010, Jun 7 [Epub ahead of print].
15. Chen J., Wildhardt G., Zhong Z., Röth R., Weiss B., Steinberger D., et al. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250kb downstream regulatory domain. J Med Genet 2009, 46:834-839.
16. Fukami M., Okuyama T., Yamamori S., Nishimura G., Ogata T. Microdeletion in the SHOX 3′ region associated with skeletal phenotypes of Langer mesomeli dysplasia in a 45,X/46,X,r(X) infant and Leri-Weil dyschondrosteosis in her 46,XX mother: implication for the SHOX enhancer. Am J Med Genet 2005, 137:72-76.
17. Rappold G., Blum W.F., Shavrikova E.P., Crowe B.J., Roeth R., Quigley C.A., et al. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet 2007, 44:306-313.
18. Leka S.K., Kitsiou-Tzeli S., Kalpini-Mavrou A., Kanavakis E. Short stature and dysmorphology associated with defects in the SHOX gene. Hormones 2006, 5:107-118.
19. Marchini A., Rappold G., Schneider K.U. SHOX at a glance: from gene to protein. Arch Biochem Biophys 2007, 113:116-123.
20. Aza-Carmona M., Shears D.J., Yuste-Checa P., Barca-Tierno V., Hisado-Oliva A., Belinchón A., et al. SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer. Hum Mol Genet 2011, 20:1547-1559.
21. Liu H., Chen C.H., Espinoza-Lewis R.A., Jiao Z., Sheu I., Hu X., et al. Functional redundancy between human SHOX and mouse Shox2 in the regulation of sinoatrial node formation and pacemaking function. J Biol Chem 2011, 19:17029-17038.
22. Durand C., Roeth R., Dweep H., Vlatkovic I., Decker E., Schneider K.U., et al. Alternative splicing and nonsense-mediated RNA decay contribute to the regulation of SHOX expression. PLoS ONE 2011, 6:e18115.
23. Rao R., Blaschke R.J., Marchini A., Niesler B., Burnett M., Rappold G.A. The Leri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activador. Hum Mol Genet 2001, 10:3083-3091.
24. Blum W.F., Cao D., Hesse V., Fricke-Otto S., Ross J.L., Jones C., et al. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res 2009, 71:167-172.
25. Clement-Jones M., Schiller S., Rao E., Blaschke R.J., Zuniga A., Zeller R., et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000, 9:695-702.
26. Munns G., Glass I. SHOX-related haploinsufficiency disorders. GeneReviews [Internet] 2005, University of Washington, Seattle, Seattle, Washington, [Initial posting: Dec 12, Last revision: Feb 1, 2008]. R.A. Pagon, T.C. Bird, C.R. Dolan, K. Stephens (Eds.).
27. Rosenfield R. Editorial: a SHOX to the system. J Clin Endocrinol Metab 2001, 86:5672-5673.
28. Schmidt B., Liebenberg V., Dietrich D., Schlegel T., Kneip C., Seegebarth A., et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 2010, 10:1-9.
29. Vickerman L., Neufeld S., Cobb J. Shox2 function couples neural, muscular and skeletal development in the proximal forelimb. Dev Biol 2011, 350:323-336.
30. Blaschke R.J., Töpfer C., Marchini A., Steinbeisser H., Janssen J.W.G., Rappold G.A. Transcriptional and translational regulation of the Leri-Weill and Turner Syndrome homeobox gene SHOX. J Biol Chem 2003, 278:47820-47826.
31. Marchini A., Häcker B., Marttila T., Hesse V., Emons J., Weiss B., et al. BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum Mol Genet 2007, 16:3081-3087.
32. Decker E., Durand C., Bender S., Rödelsperger C., Glaser A., Hecht J., et al. FGFR3 is a target of the homeobox transcription factor SHOX in limb development. Hum Mol Genet 2011, 20:1524-1535.
33. Wasniewska M., Raiola G., Nicoletti A., Galati M.C., Messina M.F., Mirabelli S., et al. Severe SHOX gene haploinsufficiency in a girl with a novel mutation (M1T) involving the first codon of coding region. J Endocrinol Invest 2010, 33:282-283.
34. Binder G., Ranke M., Martin D. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. J Clin Endocrinol Metab 2003, 88:4403-4408.
35. Thomas N.S., Harvey J.F., Nunyan D.J., Rankin J., Grigelioniene G., Bruno D.L., et al. Clinical and molecular characterization of duplications encompassing the human SHOX gene reveal a variable effect on stature. Am J Med Genet 2009, 149A:1407-1414.
36. Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr 2011, 75:81-89.
37. D'haene B., Hellemans J., Craen M., De Schepper J., Devriendt K., Fryns J.P., et al. Improved molecular diagnostics of idiopathic short stature and allied disorders: quantitative polymerase chain reaction-based copy number profiling of SHOX and pseudoautosomal region. J Clin Endocrinol Metab 2010, 95:3010-3018.
38. Andrade A.C., Baron J., Manolagas S.C., Shaw N.J., Rappold G.A., Donaldson M.D., et al. Hormones and genes of importance in bone physiology and their influence on bone mineralization and growth in Turner syndrome. Horm Res Paediatr 2010, 73:161-165.
39. Guedes A.D., Bianco B., Callou E.Q., Gomes A.L., Lipay M.V.N., Verreschi I.T.N. O hormônio de crescimento na síndrome de Turner: dados e reflexões. Arq Bras Endrocrinol Metab 2008, 52:757-764.
40. Saenger P. Turner syndrome. Pediatric endocrinology 2008, 610-661. Saunders Elsevier, Philadelphia. 3rd ed. M.A. Sperling (Ed.).
41. Ross J.L., Scott C., Mattila P., Kowal K., Nass A., Papenhausen P., et al. Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab 2001, 86:5674-5680.
42. Fukami M., Nishi Y., Hasegawa Y., Miyoshi Y., Okabe T., Haga N., et al. Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support of a disadvantageous effect of gonadal estrogens. Endocr J 2004, 51:197-200.
43. Huber C., Rosilio M., Munnich A., Cormier-Daire V., French S.H.O.X. High incidence of SHOX anomalies in individuals with short stature. J Med Gene 2006, 43:735-739. GeNeSIS Module.
44. Kosho T., Muroya K., Nagai T., Fujimoto M., Yokoya S., Sakamoto H., et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab 1999, 84:4613-4621.
45. Kim HK. Madelung deformity with Vickers ligament. Pediatr Radiol. Published online: 20 may 2009. doi:10.1007/s00247-009-1293-7.
46. Stehling C., Langer M., Nassenstein I., Bachmann R., Heindel W., Vieth V. High resolution 3.0 Tesla MR imaging findings in patients with bilateral Madelung's deformity. Surg Radiol Anat 2009, 31:551-557.
47. Zebala L.P., Manske P.R., Goldfarb C.A. Madelung's deformity: a spectrum of presentation. J Hand Surg 2007, 32A:1393-1401.
48. Blaschke R.J., Rappold G.A. SHOX: growth. Léri-Weill and Turner syndromes. Trends Endocrinol Metabol 2000, 11:227-230.
49. Ricotti S., Petrucci L., Carenzio G., Klersy C., Calcaterra V., Larizza D., et al. Prevalence and incidence of scoliosis in Turner syndrome: a study in 49 girls followed-up for 4 years. Eur J Phys Rehabil Med 2011, 47:1-7.
50. Gahunia H.K., Babyn P.S., Kirsch S., Mendonza-Londono R. Imaging of the SHOX-associated anomalies. Semin Musculoskelet Radiol 2009, 13:236-254.
51. Rappold G.A., Fukami M., Niesler B., Schiller S., Zumkeller W., Bettendorf M., et al. Deletions of the homeobox gene SHOX (Short Stature Homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab 2002, 87:1402-1406.
52. Lau N.M., Huang J.Y., MacDonald S., Elizur S., Gidoni Y., Holzer H., et al. Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online 2009, 18:290-295.
53. Hughes I.P., Choong C.S., Harris M., Ambler G.R., Cutfield W.S., Hofman P.L., et al. Growth hormone treatment for Turner syndrome in Australia reveals that younger age and increased dose interact to improve response. Clin Endocrinol (Oxf) 2011, 74:473-480.
54. Hederstierna C., Hultcrantz M., Rosenhall U. A longitudinal study of hearing decline in women with Turner syndrome. Acta Otolaryngol 2009, 27:1-8.
55. Barrenäs M.L., Nylén O., Hanson C. The influence of karyotype on the auricle, otitis media and hearing in Turner syndrome. Hear Res 1999, 138:163-170.